Healthcare, OrbiMed Closed Second Israel-Focused Venture Capital Fund, at $307M

orbimedOrbiMed, a global investment firm focused on the healthcare sector, closed its second Israel-focused venture capital fund, at approximately $307m.

Investors in OrbiMed Israel Partners II, LP, include several of the world’s largest healthcare companies, in addition to dozens of institutional investors and family offices.
Consistent with its predecessor fund, the fund will target all stages and sectors of the healthcare industry, with a focus on biopharmaceuticals, digital health, medical devices, and diagnostics companies in Israel.
It is targeting to invest in approximately 20 portfolio companies.
Where appropriate, Israel Partners II may co-invest with OrbiMed’s global private equity team, leveraging the financial and strategic resources of its 100+ team members and $15 billion global investment platform. The firm has offices in New York City, Herzliya, San Francisco, Shanghai, and Mumbai.

The Israel office, opened in 2010, is led by Dr. Nissim Darvish, Erez Chimovits, and Anat Naschitz.



Join the discussion